Stratify Genomics, Inc. Company Profile

12:14 EDT 24th March 2019 | BioPortfolio

Currently, there are 35,000 men annually who are unaware of a curable form of clinically significant prostate cancer. Relying solely on family history, 80% of prostate cancer cases would be missed. The most common screening tool, prostate-specific antigen (PSA) testing, has declined in usage due to controversial guidelines, which has led to a significant increase in metastatic prostate cancer.

News Articles [470 Associated News Articles listed on BioPortfolio]

Utilizing US Features and BRAFV600E Mutation Status to Stratify Papillary Thyroid Carcinoma

Clinicians may be able to utilize this information as an effective preoperative tool to stratify risk and determine an initial surgical approach for patients with PTC.

Stratify Genomics, Inc. Launches Prompt®, a Genetic Test for Predisposition to Prostate Cancer

Launched on 9/15, San Diego’s Stratify Genomics, Inc. announced Prompt®, a test to evaluate a man’s genetic predisposition to prostate cancer, designed to provide knowledge o...

Ten European Genomics Companies to Watch Out For

Next generation sequencing has revolutionized the biotech industry and genomics technology has changed dramatically over the last few years. There are many interesting European genomics companies, but...

M&As this week: 10x Genomics, Atlantic Research Group, AGC

10x Genomics has acquired Spatial Transcriptomics to enter the field of spatial genomics. The acquisition will enable 10x Genomics to gain...Read More... The post M&As this week: 10x Genomics, A...

10X Genomics Prepares to Hire 200 New Employees, Move into Larger Facility

Bay Area-based genomics company 10X Genomics has become one of the fastest growing privately-held companies in the region with an earnings increase of more than 2,000 percent over a three-year period.

Stratify Genomics Announces Formation of Its Scientific Advisory Board

San Diego’s Stratify Genomics, Inc. announced the formation of its Scientific Advisory Board: Dr. Gerald Andriole of Washington University in St. Louis, Dr. Christopher Kane and...

Genomics Researchers Say ‘Junk’ DNA Key to Advancing Medicine

NewsA group of genomics researchers are looking in an unlikely place in an effort to better predict individual risk of deadly diseases.Staff Author: 

Genomics England signs immunotherapy partnership with CCG

NHS England spin-out Genomics England and artificial intelligence (AI)-focused Cambridge Cancer Genomics (CCG) have announced they have entered into an...Read More... The post Genomics England signs i...

Drugs and Medications [0 Results]


PubMed Articles [299 Associated PubMed Articles listed on BioPortfolio]

Functional genomics in the era of cancer immunotherapy: challenges and clinical implications.

Current Social Media Conversations about Genetics and Genomics in Health: A Twitter-Based Analysis.

The growing availability of genomic information to the public may spur discussion about genetics and genomics on social media. Sites, including Twitter, provide a unique space for the public to access...

Bringing Genetics Home.

The promise of human genetics and genomics is nothing less than a fully tailored life, starting with medical treatments, diets, and preventative care all styled around a single genome. There's a light...

Rice Genomics: Over the Past Two Decades and Into the Future.

Domestic rice (Oryza sativa L.) is one of the most important cereal crops, feeding a large number of worldwide populations. Along with various high-throughput genome sequencing projects, rice genomics...

An International Summit in Human Genetics and Genomics: Empowering clinical practice and research in developing countries.

To help fill the knowledge gap in human genetics and genomics, an International Summit (IS) in Human Genetics and Genomics was conceived and organized by the National Human Genome Research Institute (...

Clinical Trials [189 Associated Clinical Trials listed on BioPortfolio]

JCV Antibody Program (STRATIFY-2)

Define the sero prevalence of JCV Antibody in the MS population and potentially stratify patients into lower or higher risk for developing PML based on antibody status.

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or p...

Companies [422 Associated Companies listed on BioPortfolio]

Stratify Genomics, Inc.

Currently, there are 35,000 men annually who are unaware of a curable form of clinically significant prostate cancer. Relying solely on family history, 80% of prostate cancer case...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

Center for Genomics and Bioinformatics

Center for Genomics and Bioinformatics The Center for Genomics and Bioinformatics (CGB) was launched in 1997 as a new academic department at the Karolinska Institute. Since then, the department has be...

Front Line Genomics

At Front Line Genomics our mission is to help deliver the benefits of genomics faster. Through our website, our magazine and the Festivals of Genomics, we support scientists, clin...

More Information about "Stratify Genomics, Inc." on BioPortfolio

We have published hundreds of Stratify Genomics, Inc. news stories on BioPortfolio along with dozens of Stratify Genomics, Inc. Clinical Trials and PubMed Articles about Stratify Genomics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Stratify Genomics, Inc. Companies in our database. You can also find out about relevant Stratify Genomics, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record